Cyclosporine ophthalmic Alternatives Compared
| Cyclosporine ophthalmic | Restasis | Tyrvaya |
|
|---|
| Cyclosporine ophthalmic | Restasis (cyclosporine) | Tyrvaya (varenicline) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Dry Eye Disease, Keratoconjunctivitis. cyclosporine ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dry Eye Disease. Restasis may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dry Eye Disease. Tyrvaya may also be used for purposes not listed in this medication guide. |
Related suggestions Dry Eye Disease (Keratoconjunctivitis Sicca)
Popular comparisons
|
|||||||||||||||||||||||
| More about Cyclosporine ophthalmic | More about Restasis (cyclosporine) | More about Tyrvaya (varenicline) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cyclosporine ophthalmic has an average rating of 4.6 out of 10 from a total of 273 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 48% reported a negative effect. |
Restasis has an average rating of 4.5 out of 10 from a total of 221 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 49% reported a negative effect. |
Tyrvaya has an average rating of 8.0 out of 10 from a total of 43 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 7% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: cyclosporine ophthalmic side effects in more detail. |
See also: Restasis side effects in more detail. |
See also: Tyrvaya side effects in more detail. |
||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all cyclosporine ophthalmic prices |
View all Restasis prices |
View all Tyrvaya prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Cequa, Restasis, Verkazia, Vevye | Other cyclosporine brands include: Cequa, Verkazia, Vevye | Other varenicline brands include: Champix | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
24 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 15 drugs are known to interact with cyclosporine ophthalmic:
|
A total of 15 drugs are known to interact with Restasis:
|
A total of 8 drugs are known to interact with Tyrvaya:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
December 23, 2002 |
December 23, 2002 |
October 15, 2021 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.